Home > Research > Publications & Outputs > Are Alzheimer's disease and other neurodegenera...

Links

Text available via DOI:

View graph of relations

Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?

Research output: Contribution to Journal/MagazineEditorialpeer-review

Published

Standard

Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones? / Hölscher, Christian; De Felice, Fernanda G.; Greig, Nigel et al.
In: Neuropharmacology, Vol. 136, No. Part B, 01.07.2018, p. 159.

Research output: Contribution to Journal/MagazineEditorialpeer-review

Harvard

APA

Vancouver

Hölscher C, De Felice FG, Greig N, Ferreira ST. Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones? Neuropharmacology. 2018 Jul 1;136(Part B):159. Epub 2018 May 18. doi: 10.1016/j.neuropharm.2018.05.021

Author

Hölscher, Christian ; De Felice, Fernanda G. ; Greig, Nigel et al. / Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?. In: Neuropharmacology. 2018 ; Vol. 136, No. Part B. pp. 159.

Bibtex

@article{2338f33b6d4f49c4837ad9bc48781036,
title = "Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?",
author = "Christian H{\"o}lscher and {De Felice}, {Fernanda G.} and Nigel Greig and Ferreira, {Sergio T.}",
year = "2018",
month = jul,
day = "1",
doi = "10.1016/j.neuropharm.2018.05.021",
language = "English",
volume = "136",
pages = "159",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Ltd",
number = "Part B",

}

RIS

TY - JOUR

T1 - Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?

AU - Hölscher, Christian

AU - De Felice, Fernanda G.

AU - Greig, Nigel

AU - Ferreira, Sergio T.

PY - 2018/7/1

Y1 - 2018/7/1

U2 - 10.1016/j.neuropharm.2018.05.021

DO - 10.1016/j.neuropharm.2018.05.021

M3 - Editorial

VL - 136

SP - 159

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - Part B

ER -